Close/positive margins after breast-conserving therapy: Additional resection or no resection?

Breast

Volumn 22, Issue S2, 2013, Pages

  Wood, William C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast conserving therapy; Margins; Re excision

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLOSE MARGIN; HISTOPATHOLOGY; IRRADIATION; MEDICAL DECISION MAKING; MORBIDITY; PARTIAL MASTECTOMY; PATIENT ABANDONMENT; POSITIVE MARGIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SURGICAL TECHNIQUE; SYSTEMIC THERAPY;

BREAST CONSERVING THERAPY; MARGINS; RE-EXCISION;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; DECISION MAKING; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; REFERENCE VALUES; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAFETY MANAGEMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84884725587     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.022     Document Type: Article

References (25)

1. Houssami N., Macaskill P., Marinovich M.L., et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010, 46:3219-3232.
2. NIH Consensus Conference Report, Wood W.C. Treatment of early-stage breast cancer. JAm Med Assoc 1991, 265:391-395. conf and panel chair.
3. Vaidya J.S., Vyas J.J., Chinoy R.F., Merchant N., Sharma O.P., Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J of Cancer 1996, 74:820-824.
4. Holland R., Veling S., Mravunac M., Hendrics J.H.C.L. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast conserving surgery. Cancer 1985, 56:979-990.
5. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. NEngl J Med 2002, 347:1233-1241.
6. Anderson S.J., Wapnir I., Dignam J.J., et al. Prognosis after ipsilateral breast tumorrecurrence and locoregional recurrences in patients treated by breast-conserving therapy in five NSABP protocols of node-negative breast cancer. JClin Oncol 2009, 27:2466-2473.
7. Turnbull L., Brown S., Harvey I., et al. Comparative effectiveness of MRI in breastcancer (COMICE) trial: a randomized controlled trial. Lancet 2010, 375:563-571.
8. Miller B.T., Abbott A.M., Tuttle T.M. The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol 2012, 19:536-540.
9. Krekel N., Zonderhuis B., Muller S., et al. Excessive resections in breast-conserving surgery: a retrospective multicenter study. Breast J 2011, 17:602-609.
10. Park C.P., Misumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. JClin Oncol 2000, 18:1668-1675.
11. McCahill L.E., Single R.M., Bowles E.J.A., et al. Variability in reexcision following breast conservation surgery. JAm Med Assoc 2012, 307:467-475.
12. Christy C.J., Thorsteinsson D., Grube B.J., et al. Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter. Ann Surg Oncol 2009, 16:697-702.
13. Rizzo M., Iyengar R., Gabram S.G.A., et al. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status,volume of resection, and pathologist workload. Ann Surg Oncol 2010, 17:228-234.
14. Coopey S.B., Buckley J.M., Bl Smith, et al. Lumpectomy cavity shaved margins do not impact re-excision rates in breast cancer patients. Ann Surg Oncol 2011, 18:3036-3040.
15. Osborn J.B., Keeney G.L., Jakub J.W., Degnim A.C., Boughey J.C. Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins. Ann Surg Oncol 2011, 18:3204-3209.
16. Krekel N.M., Haloua M.H., Lopes Cardozo A.M., et al. Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicenter, randomized controlled trial. Lancet Oncol 2013, 14:48-54.
17. Klimberg V.S., Boneti C., Adkins L.L., et al. Feasibility of percutaneous excision followed by ablation for local control in breast cancer. Ann Surg Oncol 2011, 18:3079-3087.
18. Singletary S.E. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002, 184:383-393.
19. Revesz E., Khan S.A. What are safe margins of resection for invasive and in situ breast cancer?. Oncology 2011, 25:890-895.
20. Morrow M., Harris J.R., Schnitt S.J. Surgical margins in lumpectomy for breast cancer-bigger is not better. NEngl J Med 2012, 367:79-82.
21. Mamounas E.P., Anderson S.J., Dignam J.J., et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of NSABP B-18 and B-27. JClin Oncol 2012, 30:3960-3966.
22. Dimirci S., Broadwater G., Marks L.B., Clough R., Prosnitz L.R. Breast conservation therapy: the influence of molecular subtype and margins. Int J Radiat Oncol Biol Phys 2012, 83:814-820.
23. Aziz D., Rawlinson E., Narod S.A., et al. The role of reexcision for positive margins in optimizing local disease control after breast - conserving surgery for cancer. Breast J 2006, 12:331-337.
24. Jung W., Kang E., Kim S.M., et al. Factors associated with re-excision after breast conserving surgery for early-stage breast cancer. JBreast Cancer 2012, 15:412-419.
25. Ciocca R.M., Li T., Freedman G.M., Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008, 15:2263-2271.